Profile picture of Joanne Tan

Dr Joanne Tan

Profile picture of Joanne Tan

MBBS (Hons), FRACP

Medical Oncologist
Call
Referrals

Dr Joanne Tan is committed to providing her patients with comprehensive and personalised cancer care. Her compassionate approach to care and strong attention to detail reassures patients that they are in the best hands.

Biography

Dr Joanne Tan is a medical oncologist at Icon Cancer Centre Townsville. She completed a Bachelor of Medicine, Bachelor of Surgery (MBBS) at James Cook University and undertook advanced medical oncology training at tertiary hospitals in Brisbane and Townsville, Queensland.

In 2017, Dr Tan became a fellow of the Royal Australasian College of Physicians (FRACP). She was subsequently appointed as a medical oncology staff specialist at Bundaberg Hospital, where she provided care to a wide range of cancer patients in the Wide Bay district, before returning to Townsville in late 2023. Alongside her practice at Icon, Dr Tan holds a medical oncology staff specialist appointment at Townsville University Hospital.

Dr Tan is a strong advocate for medical education, local research and clinical trials. She enjoys participating in cancer education and telechemotherapy programs to improve health outcomes in rural and regional areas. She has been an associate senior lecturer at the University of Queensland’s Rural Clinical School and remains actively involved in medical student and junior doctor education.

Dr Tan’s clinical experience covers a wide range of solid tumour malignancies, with a special interest in gastrointestinal cancer, gynaecological cancer and breast cancer.

Publications

    • The Weighted Activity Unit (WAU) effect: evaluating the cost of Diagnosis Related Group (DRG) coding. J.Y.A. Tan, C. Senko, B. Hughes, Z. Lwin, R. Bennett, J. Power & L. Thomson. Internal Medicine Journal 2020; 50 (4); 440-444.
    • A prospective comparison of times to presentation and treatment of regional and remote head and neck patients in North Queensland, Australia. J.Y.A. Tan, Z.A. Otty, V.N. Vangaveti, P. Buttner, S.C. Varma, A.J. Joshi, J. Kelly, M. Collins & S.S. Sabesan. Internal Medicine Journal 2016; 46 (8); 917-924.
    • Palliative embolisation for intrapulmonary shunting in lepidic predominant adenocarcinoma of the lung. J.Y.A. Tan, D. Walters, K. Poon, P. Zimmerman & P. Aldons. Respiratory Medicine Case Reports 2015; 15: 121 -124.
    • HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death. J.D. Lickliter, N.J. Wood, L. Johnson, G. McHugh, J. Tan, F. Wood, J. Cox & N.W. Wickham. 2003 Nov; 17(11): 2074-80.

Special Interests

Dr Joanne Tan accepts referrals for all cancer types, with a special clinical interest in:

  • Breast cancer
  • Gastrointestinal cancer
  • Gynaecological cancer

Languages spoken

  • English

Icon Locations

Visiting Locations

  • Townsville University Hospital

Affiliations & Memberships

  • Australasian Gastrointestinal Trials Group (AGITG)
  • Australian Medical Association Queensland (AMAQ)
  • Breast Cancer Trials Australia
  • Clinical Oncology Society of Australia (COSA)
  • Medical Oncology Group of Australia (MOGA)
  • Royal Australasian College of Physicians (RACP)

Publications

    • The Weighted Activity Unit (WAU) effect: evaluating the cost of Diagnosis Related Group (DRG) coding. J.Y.A. Tan, C. Senko, B. Hughes, Z. Lwin, R. Bennett, J. Power & L. Thomson. Internal Medicine Journal 2020; 50 (4); 440-444.
    • A prospective comparison of times to presentation and treatment of regional and remote head and neck patients in North Queensland, Australia. J.Y.A. Tan, Z.A. Otty, V.N. Vangaveti, P. Buttner, S.C. Varma, A.J. Joshi, J. Kelly, M. Collins & S.S. Sabesan. Internal Medicine Journal 2016; 46 (8); 917-924.
    • Palliative embolisation for intrapulmonary shunting in lepidic predominant adenocarcinoma of the lung. J.Y.A. Tan, D. Walters, K. Poon, P. Zimmerman & P. Aldons. Respiratory Medicine Case Reports 2015; 15: 121 -124.
    • HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death. J.D. Lickliter, N.J. Wood, L. Johnson, G. McHugh, J. Tan, F. Wood, J. Cox & N.W. Wickham. 2003 Nov; 17(11): 2074-80.

Search

Contact us
Become a patient